Form D · Other
VITALIEF, INC.
New Brunswick, NJ · CIK 0001927172
Offering snapshot reported Apr 26, 2023 · SEC filing
- Reported sold
- $2M Offering amount: $3M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 13, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 26, 2023 | Initial | $2,000,000 | No comparison | 3 | SEC filing |
| May 5, 2022 | Initial | $2,750,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-480016
Source: Form D, filed Apr 26, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Doll | Director |
| David Granese | Executive |
| Mark E. Kolb | Director |
| Steven Libutti, M.D. | Director |
| Kirk Mc Poyle | Executive |
| David C. Moore | Director, Executive |
| Reynold A. Panettieri, M.D. | Director |
Issuer details
Industry: Other (See others in industry)
Address:
317 George Street Suite 320
New Brunswick, NJ, 08901
New Brunswick, NJ, 08901